Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Evotec SE

EVONASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$3.37
$-0.16(-4.53%)
U.S. Market opens in 12h 41m

Evotec SE (EVO) Stock Overview

Explore Evotec SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-6.37
EPS (TTM)$-0.53
ROE-0.17%
Fundamental Analysis

AI Price Forecasts

1 Month$1.95
3 Months$2.28
1 Year Target$1.25

EVO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Evotec SE (EVO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.42, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.25.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.37 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.53%
5-Day Change
-6.13%
1-Month Change
-6.65%
3-Month Change
13.47%
6-Month Change
-7.42%
Year-to-Date (YTD) Change
5.97%
1-Year Change
-24.44%
3-Year Change
-65.04%
5-Year Change
-83.24%
All-Time (Max) Change
227.18%

Contact Information

49 40 560 81 0
Essener Bogen 7, Hamburg, NaN, 22419

Company Facts

47,660 Employees
IPO DateFeb 5, 2004
CountryDE
Actively Trading

Frequently Asked Questions